Atrial Fibrillation Also called: AF, Afib

Clinical Trial Finder

Many patients with atrial fibrillation are interested in participating in the latest research regarding their condition. This Clinical Trial Finder can help you—or a loved one—easily find ongoing cardiovascular clinical research trials for which you might qualify. This list is a service of the U.S. National Institutes of Health called clinicaltrials.gov, a database of publicly and privately supported clinical studies.

Simply click on the trial below that interests you to learn how you might participate.

Coagulation Activity and Thrombogenesis in Patients With Atrial Fibrillation

Condition:   Atrial Fibrillation
Interventions:   Procedure: circumferential ablation;   Device: SVT ablation
Sponsor:   Tel-Aviv Sourasky Medical Center
Not yet recruiting - verified May 2015

Apixaban in Patients Who Undergo CIED Procedure- Randomized Pilot Study

Condition:   Atrial Fibrillation
Interventions:   Drug: Apixaban;   Drug: Warfarin
Sponsors:   Mayo Clinic;   Bristol-Myers Squibb
Not yet recruiting - verified May 2015

Rivaroxaban Evaluation in Real Life Settings

Conditions:   Atrial Fibrillation;   Stroke
Intervention:  
Sponsors:   Thrombosis Research Institute;   Bayer
Recruiting - verified May 2015

Non-invasive Blood Pressure and Cardiac Output Measurement by Using Applanation Tonometry

Conditions:   Atrial Fibrillation;   Left Ventricular Failure;   Left Ventricular Impaired Function;   Aortic Valve Stenosis
Intervention:  
Sponsor:   Universitätsklinikum Hamburg-Eppendorf
Not yet recruiting - verified May 2015

Hybrid Versus Catheter Ablation in Persistent AF

Condition:   Atrial Fibrillation
Interventions:   Procedure: Hybrid Ablation;   Procedure: Catheter Ablation
Sponsors:   Maastricht University Medical Center;   AtriCure, Inc.
Not yet recruiting - verified May 2015

Profile and Antithrombotic Management of Patients With NVAF Attending Internal Medicine Departments in Spain (PERFILAR Study)

Condition:   Anticoagulation, Blood Thinners , Atrial Fibrillation, Bleeding, Stroke
Intervention:  
Sponsor:   Bristol-Myers Squibb
Recruiting - verified May 2015

Amplatzer™Amulet™ Post-Market Study

Conditions:   Atrial Fibrillation;   Thromboembolism;   Stroke
Intervention:   Device: Subjects implanted with Amulet Device
Sponsor:   St. Jude Medical
Active, not recruiting - verified May 2015

Cost of Monitoring Patients Treated With Vitamin K Antagonists in Spain

Condition:   Anticoagulation
Intervention:  
Sponsors:   Bristol-Myers Squibb;   Badalona Serveis Assistencial ;   IMS Health
Active, not recruiting - verified May 2015

Effectiveness of Ripple Mapping in Atrial Tachycardia Ablation

Condition:   Atrial Tachycardia
Interventions:   Device: Ripple Mapping guided AT ablation;   Device: Conventional AT ablation
Sponsor:   Imperial College London
Not yet recruiting - verified March 2015

Program for the Identification of "Actionable" Atrial Fibrillation in the Family Practice Setting

Condition:   Atrial Fibrillation
Interventions:   Other: 30 Second Pulse Check;   Device: Watch BP Home A;   Device: HeartCheck Hand-held ECG device
Sponsors:   Population Health Research Institute;   Canadian Institutes of Health Research  (CIHR)
Recruiting - verified May 2015

Evaluation of Potential Off-label Use of Dabigatran Etexilate in Europe

Condition:   Atrial Fibrillation
Intervention:  
Sponsor:   Boehringer Ingelheim
Recruiting - verified May 2015

Role of Cardiac Biomarkers in Prediction of Outcome in Atrial Fibrillation Patients Undergoing Catheter Ablation

Condition:   Atrial Fibrillation
Intervention:   Procedure: Radio-frequency catheter ablation
Sponsor:   Texas Cardiac Arrhythmia Research Foundation
Active, not recruiting - verified May 2015

Cologne Cardioversion Study

Conditions:   Atrial Arrhythmia;   Heart Failure
Interventions:   Device: Internal Electrocardioversion;   Device: External Electrocardioversion
Sponsors:   Universitätsklinikum Köln ;   Medtronic;   St. Jude Medical
Recruiting - verified May 2015

Efficacy, Safety and Efficiency of the nMARQ Pulmonary Vein Isolation System in Paroxysmal Atrial Fibrillation

Condition:   Paroxysmal Atrial Fibrillation
Intervention:   Procedure: ablation
Sponsors:   Basildon and Thurrock University Hospitals NHS Foundation Trust;   Anglia Ruskin University
Recruiting - verified May 2015

A Blinded Study to Evaluate Effect on Atrial Fibrillation Burden in Patients With Paroxysmal Atrial Fibrillation

Condition:   Paroxysmal Atrial Fibrillation
Interventions:   Drug: BMS-919373;   Drug: Placebo (Matching with BMS-919373)
Sponsor:   Bristol-Myers Squibb
Recruiting - verified April 2015

Renal Nerve Denervation in Patients With Hypertension and Paroxysmal and Persistent Atrial Fibrillation

Conditions:   Atrial Fibrillation;   Hypertension
Interventions:   Drug: Renal nerve denervation;   Device: Cryoablation
Sponsor:   Medtronic Atrial Fibrillation Solutions
Recruiting - verified May 2015

Study Of The Blood Thinner, Apixaban, For Patients Who Have An Abnormal Heart Rhythm (Atrial Fibrillation) And Expected To Have Treatment To Put Them Back Into A Normal Heart Rhythm (Cardioversion)

Condition:   Atrial Fibrillation
Interventions:   Drug: Apixaban;   Drug: Parenteral heparin and/or oral Vitamin K antagonist
Sponsors:   Pfizer;   Bristol-Myers Squibb
Recruiting - verified May 2015

Apixaban for the Reduction of Thrombo-Embolism in Patients With Device-Detected Sub-Clinical Atrial Fibrillation

Conditions:   Atrial Fibrillation;   Stroke
Interventions:   Drug: Apixaban;   Drug: aspirin
Sponsors:   Population Health Research Institute;   Bristol-Myers Squibb;   Pfizer;   Medtronic
Recruiting - verified May 2015

Risk of Stroke and Silent Cerebrovascular Thromboembolism After Cardioversion of Atrial Fibrillation

Conditions:   Atrial Fibrillation;   Cardioversion;   Cerebrovascular Stroke
Interventions:   Procedure: Cardioversion;   Drug: warfarin
Sponsor:   Suleyman Demirel University
Recruiting - verified October 2014

A Feasibility Study to Evaluate the Effect of Concomitant Renal Denervation and Cardiac Ablation on AF Recurrence

Conditions:   Persistent Atrial Fibrillation;   Paroxysmal Atrial Fibrillation;   Hypertension;   Renal Denervation;   Cardiac Ablation
Interventions:   Device: Renal Artery Ablation Catheter;   Device: Cardiac Ablation
Sponsor:   St. Jude Medical
Recruiting - verified May 2015

Non-interventional Local Study on Prescription Behavior of Anticoagulation Therapy in Secondary Stroke Prevention in Atrial Fibrillation Patients

Conditions:   Stroke,;   Embolism
Intervention:   Other: Rivaroxaban ( Xarelto, BAY59-7939)
Sponsor:   Bayer
Active, not recruiting - verified May 2015

Assessment of an Education and Guidance Programme for Eliquis Adherence in Non-Valvular Atrial Fibrillation (AEGEAN)

Condition:   Non-valvular Atrial Fibrillation
Intervention:   Drug: Apixaban
Sponsor:   Bristol-Myers Squibb
Recruiting - verified December 2014

Belgian Real Life Non-interventional Study (NIS) on Xarelto in Non-valvular Atrial Fibrillation (AF) Patients Treated for the Prevention of Stroke and Systemic Embolism

Condition:   Atrial Fibrillation
Intervention:   Drug: Rivaroxaban (Xarelto, BAY59-7939)
Sponsor:   Bayer
Completed - verified May 2015

A Study Exploring Two Strategies of Rivaroxaban (JNJ39039039; BAY-59-7939) and One of Oral Vitamin K Antagonist in Patients With Atrial Fibrillation Who Undergo Percutaneous Coronary Intervention

Conditions:   Atrial Fibrillation;   Percutaneous Coronary Intervention
Interventions:   Drug: rivaroxaban 2.5 mg;   Drug: rivaroxaban 15 mg;   Drug: rivaroxaban 10 mg;   Drug: aspirin (ASA);   Drug: vitamin K antagonist (VKA);   Drug: clopidogrel;   Drug: prasugrel;   Drug: ticagrelor
Sponsors:   Janssen Scientific Affairs, LLC;   Bayer
Recruiting - verified May 2015

The Concomitant Cryomaze Procedure Using Nitreous Oxide Cryoprobe: Comparison With Argon Based Cryoprobe

Conditions:   Atrial Fibrillation;   Valve
Interventions:   Device: Cryomaze procedure using Nitrous oxide;   Device: Cryomaze procedure using Argon
Sponsor:   Samsung Medical Center
Recruiting - verified March 2013

Xarelto for Prevention of Stroke in Patients With Atrial Fibrillation in Asia

Condition:   Atrial Fibrillation
Intervention:   Drug: Rivaroxaban (Xarelto, BAY59-7939)
Sponsor:   Bayer
Recruiting - verified May 2015

Does Atrial Fibrillation (AF) Termination Without Additional Ablation Influence Outcome?

Condition:   Atrial Fibrillation
Interventions:   Procedure: PVAI;   Procedure: PVAI + ablation of extraPV triggers
Sponsors:   Texas Cardiac Arrhythmia Research Foundation;   California Pacific Medical Center
Recruiting - verified May 2015

Evaluation of the Phased Radio Frequency Ablation System

Condition:   Persistent Atrial Fibrillation
Intervention:   Device: Medtronic Phased RF Ablation System
Sponsor:   Medtronic Atrial Fibrillation Solutions
Recruiting - verified May 2015

Pulmonary Vein Antrum Isolation (PVAI) Plus Isolation of Complex Fractionated Atrial Electrograms (CAFE) and Non-PV Triggers Ensure Long-term Recurrence-free Survival in Non-paroxysmal Atrial Fibrillation

Conditions:   Persistent Atrial Fibrillation;   Long-standing Persistent Atrial Fibrillation
Interventions:   Procedure: Pulmonary Vein Antrum Isolation;   Procedure: CFAE ablation;   Procedure: Isolation of non-PV triggers
Sponsors:   Texas Cardiac Arrhythmia Research Foundation;   California Pacific Medical Center
Recruiting - verified May 2015

PV Reconnection After PVAI at Different Power Settings and Adenosine Provocation

Condition:   Paroxysmal Atrial Fibrillation
Intervention:   Procedure: PVAI followed by adenosine provocation
Sponsors:   Texas Cardiac Arrhythmia Research Foundation;   California Pacific Medical Center
Recruiting - verified May 2015

Outcome of Atrial Fibrillation Ablation After Permanent Pulmonary Vein Antrum Isolation With or Without Proven Left Atrial Posterior Wall Isolation

Condition:   Atrial Fibrillation
Interventions:   Procedure: Pulmonary vein antrum isolation (PVAI);   Procedure: PVAI plus left atrial posterior wall (LAPW) isolation
Sponsors:   Texas Cardiac Arrhythmia Research Foundation;   Centro Cardiologico Monzino;   Catholic University of the Sacred Heart;   Capital Medical University
Recruiting - verified May 2015

Comparison of Treatment of Atrial Fibrillation (AF) Between Surgical Ultrasonic Technology or Drug Therapy for Patients With AF Requiring Mitral Valve Surgery

Conditions:   Mitral Valvulopathy;   Atrial Fibrillation
Interventions:   Device: EPICOR;   Drug: Amiodarone
Sponsors:   Centre Hospitalier Universitaire de Saint Etienne;   Ministry of Health, France
Recruiting - verified May 2015

Antazoline in Rapid Cardioversion of Paroxysmal Atrial Fibrillation

Condition:   Paroxysmal Atrial Fibrillation
Interventions:   Drug: antazoline;   Drug: 0.9% saline
Sponsor:   Institute of Cardiology, Warsaw, Poland
Completed - verified May 2015

Variant of Stimulation in Atrioventricular Node Ablation (VISTA) in Patients With Atrial Fibrillation and Moderate Chronic Heart Failure

Condition:   Heart Failure
Interventions:   Device: Implantation of CRT device;   Device: Implantation of conventional VVI(R) pacemaker
Sponsor:   Federal North-West Medical Research Centre
Recruiting - verified January 2014

Vernakalant Versus Ibutilide In Recent-Onset Atrial Fibrillation

Condition:   Atrial Fibrillation
Interventions:   Drug: Brinavess (Vernakalant);   Drug: Corvert (Ibutilide)
Sponsor:   Medical University of Vienna
Completed - verified May 2015

Effect of Catheter Ablation on Clinical Course of Migraine in AF Patients With or Without Previous History of Migraine

Conditions:   Migraine;   Atrial Fibrillation
Interventions:   Procedure: Radiofrequency catheter ablation;   Procedure: Radiofrequency catheter ablation
Sponsor:   Texas Cardiac Arrhythmia Research Foundation
Recruiting - verified May 2015

INFLACOR - Clinical and Genetic Predictors of Inflammation Related Complications After Heart Surgery

Condition:   Systemic Inflammatory Response Syndrome
Intervention:   Procedure: cardiac surgery with CPB use
Sponsors:   Medical University of Gdansk;   Ministry of Science and Higher Education, Poland
Completed - verified May 2015

Role of Coumadin in Preventing Thromboembolism in Atrial Fibrillation (AF) Patients Undergoing Catheter Ablation

Condition:   Thromboembolism
Interventions:   Drug: Coumadin;   Drug: Coumadin;   Drug: Coumadin
Sponsors:   Texas Cardiac Arrhythmia Research Foundation;   University of Kansas;   California Pacific Medical Center;   Stanford University;   Case Western Reserve University;   Southlake Regional Health Centre;   Catholic University, Italy
Completed - verified May 2015

Get CardioSmart

You're Invited

CardioSmart Points

Log in to Check Your Balance
and Go Shopping

Learn how to earn more CardioSmart Points